( October 17, 2024, 8:09 AM EDT) -- WASHINGTON, D.C. — Novartis Pharmaceuticals Corp. filed notice that it intends to appeal a decision by a District of Columbia district court judge to deny its motion for summary judgment and find that the U.S. Food and Drug Administration did not violate federal law in approving a generic version of its heart failure drug Entresto....